Presentation is loading. Please wait.

Presentation is loading. Please wait.

Menachem M Meller,MD, PhD

Similar presentations


Presentation on theme: "Menachem M Meller,MD, PhD"— Presentation transcript:

1 Menachem M Meller,MD, PhD
The Feasibility and Impact of Using Large Administrative Databases to Evaluate The Significance of Obesity as a Risk Factor in THR Norman A Johanson, MD Menachem M Meller,MD, PhD Mark H Gonzales, MD, PhD Nader Toossi, MD Min-sun Son,PhD Edmund Lau, MS

2 We have nothing to disclose.

3 BMI Classification by WHO
Underweight < 18.5 kg/m2 Normal range kg/m2 Overweight ≥ 25 kg/m2 Pre-obese kg/m2 Obese ≥ 30 kg/m2 Obese class I kg/m2 Obese class II kg/m2 Obese class III (morbidly obese) ≥ 40.0 kg/m2

4 Obesity Epidemics More than % 30 of US adult population are obese
Morbid and super obesity prevalence grow 2 & 3 times faster, respectively, than moderate obesity Currently, higher proportions of patients undergoing THR are obese

5 The current literature on the effect of obesity on the outcome of THA:
Inconclusive Controversial Small sample sizes Higher strata of obesity (super obesity) not investigated Not all confounding factors considered

6 Bundled payment program for hip and knee replacement proposed by CMS, based on CCJR model
Need to identify high-risk groups in total joint replacement patients, and high-cost complications and readmissions

7 The Purpose The purpose of this study is to determine the risk and cost of 90-day postoperative complications following primary THA in elderly morbidly obese (BMI ≥ 40 kg/m2) during and in elderly super-obese patients (BMI ≥ 50 kg/m2) during 2010(Q4)-2013

8 Methods Retrospective cohort study of Medicare inpatient claims data accessed through a limited dataset (LDS) format Inclusion Criteria: Age ≥ 65 y/o Enrollment in Medicare at least one year before admission Residing in 50 US states Exclusion Criteria: Knee arthroplasty procedure during the study period

9 Methods Tracking of patients for 90 days after the index surgery (January 1, 2008 through December 31, 2013) Since October 2010, further stratification of patients with BMI ≥ 40 kg/m2 has been possible through ICD-9 diagnosis codes. Thus, the opportunity to identify super-obese patients Hazard ratio calculated for each complication using multivariate Cox models

10 ICD-9-CM Codes Used to Identify Postoperative Complications
Identification Death Medicare Enrollment Data DVT 453.40, , , 453.8x, 453.2x, 451.1x, PJI 996.66 Revision 81.53, 00.70, 00.71, 00.72, 00.73 Pulmonary Embolism 415.1x Implant Failure 996.4x, Wound Dehiscence 998.30, , MI 410.0x – 410.9x Pneumonia 480.x – 486.x Dislocation 996.42 Readmission Subsequent Claim Records in 90 Days Acute Renal Failure 584.x

11 Results 2008–2013 2010(Q4) – 2013 Age (average) 75.0 ± 6.7 70.6 ± 4.8
Normal Weight (BMI<25 kg/m2) Morbidly Obese (BMI≥40 kg/m2) Super Obese (BMI≥50 kg/m2) Age (average) 75.0 ± 6.7 70.6 ± 4.8 69.8 ± 4.3 Female 62% 68% 76% Caucasian African American Others 94% 89% 87% 4% 9% 12% 2% 1% Number of patients 514,422 9,932 570

12 Morbid Obesity Super Obesity
Complications Hazard Ratio P-value Hazard Ratio P-value Wound Dehiscence 4 <0.001 9.4 Periprosthetic Joint Infection 3.8 <0.00 6.3 Revision 2.1 1.6 Non-significant Renal Failure 1.7 Readmission 1.5 DVT 1.4 0.002 Pulmonary Embolism 1.2 Implant Failure 0.9 90-day post-THA significant complications and corresponding hazard ratios comparing super and morbidly obese patients with the normal-weight, adjusted for age, sex, race, economic status, Charlson Comorbidity Index, institutional factors and the experience of surgeon Periprosthetic Joint Infection 6.27 <0.001 Readmission 2.11 Renal Failure 1.72 Wound Dehiscence 9.35

13 Dose-response relationship between obesity and
Wound Dehiscence 9.4 HR BMI Level ( kg/m2)

14 Dose-response relationship between obesity and
Periprosthetic Joint Infection 6.3 HR BMI Level ( kg/m2)

15 Dose-response relationship between obesity and
Readmission 2.1 HR BMI Level ( kg/m2)

16 from the initial THA through the postoperative 90 days
Total hospital charges of patient with normal BMI, BMI 40-49, and BMI≥50 from the initial THA through the postoperative 90 days $

17 Conclusion Morbid obesity, in general, and super obesity, in particular, are associated with increased risk and cost of specific 90-day postoperative complications following primary THA in elderly patients. Knowledge of the excess hospital costs during the 90-day post-THA period in super-obese patients may have implications in negotiating CMS bundled payments and charge carve outs.

18 Thank you Thank you Hahnemann University Hospital


Download ppt "Menachem M Meller,MD, PhD"

Similar presentations


Ads by Google